Helen Shi1, Iulianna Bobanga2, Christopher R McHenry3. 1. Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA. 2. Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA; Department of Surgery, University Hospitals Case Medical Center, Cleveland, OH, 44106, USA. 3. Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA; Department of Surgery, MetroHealth Medical Center, Cleveland, OH, 44109, USA. Electronic address: cmchenry@metrohealth.org.
Abstract
INTRODUCTION: Our aim was to investigate whether benign thyroid nodules ≥ 4 cm have a higher malignancy rate. METHODS: A retrospective review of patients with a nodule and a benign FNAB who underwent thyroidectomy was completed. Patients were divided into two groups; nodule size: < 4 cm or ≥4 cm, and clinical factors, nodule size and rates of malignancy were compared. RESULTS: 337 patients underwent thyroidectomy: 99 had nodules <4 cm (2.8 ± 0.58 cm) and 238 had nodules ≥ 4 cm (5.9 ± 1.97 cm). Seven (2.1%) patients had cancer, 2 (2.0%) with a nodule < 4 cm and 5 (2.1%) with a nodule ≥ 4 cm (p = 0.962). There was no difference in clinical factors between groups (p > 0.05). CONCLUSION: There is no difference in rates of malignancy for nodules < 4 cm or ≥ 4 cm. Thus, thyroidectomy should not be recommended based solely on nodule size.
INTRODUCTION: Our aim was to investigate whether benign thyroid nodules ≥ 4 cm have a higher malignancy rate. METHODS: A retrospective review of patients with a nodule and a benign FNAB who underwent thyroidectomy was completed. Patients were divided into two groups; nodule size: < 4 cm or ≥4 cm, and clinical factors, nodule size and rates of malignancy were compared. RESULTS: 337 patients underwent thyroidectomy: 99 had nodules <4 cm (2.8 ± 0.58 cm) and 238 had nodules ≥ 4 cm (5.9 ± 1.97 cm). Seven (2.1%) patients had cancer, 2 (2.0%) with a nodule < 4 cm and 5 (2.1%) with a nodule ≥ 4 cm (p = 0.962). There was no difference in clinical factors between groups (p > 0.05). CONCLUSION: There is no difference in rates of malignancy for nodules < 4 cm or ≥ 4 cm. Thus, thyroidectomy should not be recommended based solely on nodule size.
Authors: Muhammed Kizilgul; Rupendra Shrestha; Angela Radulescu; Maria R Evasovich; Lynn A Burmeister Journal: Endocrine Date: 2019-05-29 Impact factor: 3.633
Authors: M Jinih; F Faisal; K Abdalla; M Majeed; A A Achakzai; C Heffron; J McCarthy; H P Redmond Journal: Ann R Coll Surg Engl Date: 2019-12-23 Impact factor: 1.891
Authors: Samantha N Steinmetz-Wood; Amanda G Kennedy; Bradley J Tompkins; Matthew P Gilbert Journal: Int J Endocrinol Date: 2022-04-16 Impact factor: 2.803
Authors: Whitney Sutton; Joseph K Canner; Lisa M Rooper; Jason D Prescott; Martha A Zeiger; Aarti Mathur Journal: Am J Surg Date: 2020-06-02 Impact factor: 2.565